<p>The Japanese encephalitis (JE) vaccine was introduced to the national immunization program in 1985, which has led to a dramatic decrease in the number of reported cases, but JE continues to occur in foreign nationals residing in or traveling to Korea. Although the incidence is low, this study demonstrated that more Koreans were infected with JE than foreign-born expatriates. The incidence rates of Korean-born nationals were between 0.01 and 0.08 cases per 100,000. In contrast, the incidence rates of foreign-born nationals ranged between 0 and 0.26 cases per 100,000. The incidence rates clearly showed that foreign-born expatriates were more at risk, which underscores the importance of vaccination. We recommend heightened surveillance among JE-susceptible individuals and promote vaccination among foreign-born nationals living in Korea.</p>
Citations
Citations to this article as recorded by
Seroprevalence of Japanese Encephalitis Virus, and Immunogenicity of the Vero-Cell Culture-Derived Vaccine in Hematopoietic Stem Cell Transplantation Recipients Haejeong Lee, Ji-Man Kang, Minyoung Kim, Hyojung Park, Bonhyang Na, Younhee Park, Jong Gyun Ahn, Eunyoung Lee, Hyewon Lee, Hyeon Jin Park, Hyeon-Seok Eom Journal of Korean Medical Science.2026;[Epub] CrossRef
Development of a novel antigen for hemagglutination inhibition of Japanese encephalitis virus genotype 5 Dong-Kun Yang, Gyu-Nam Park, Ju-Yeon Lee, Hye Jeong Lee, Gyeong Hui Kwon, Yun Sang Cho Korean Journal of Veterinary Research.2025; 65(4): e22. CrossRef
Japanese encephalitis in a U.S. traveler returning from Vietnam, 2022 Zachary C. Janatpour, M. Andrew Boatwright, Sara M. Yousif, Maria-Fernanda Bonilla, Kelly A. Fitzpatrick, Susan L. Hills, Catherine F. Decker Travel Medicine and Infectious Disease.2023; 52: 102536. CrossRef
Travel vaccines—priorities determined by incidence and impact Robert Steffen, Lin H Chen, Peter A Leggat Journal of Travel Medicine.2023;[Epub] CrossRef
Molecular Mechanism and Role of Japanese Encephalitis Virus Infection in Central Nervous System-Mediated Diseases Pardeep Yadav, Pratik Chakraborty, Niraj Kumar Jha, Saikat Dewanjee, Abhimanyu Kumar Jha, Siva Prasad Panda, Prabhu Chandra Mishra, Abhijit Dey, Saurabh Kumar Jha Viruses.2022; 14(12): 2686. CrossRef
Retention of neutralizing antibodies to Japanese encephalitis vaccine in age groups above fifteen years in Korea Hee-Jung Lee, Hanul Choi, Ki Hoon Park, Yuyeon Jang, Young-jin Hong, Young Bong Kim International Journal of Infectious Diseases.2020; 100: 53. CrossRef
Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices Susan L. Hills, Emmanuel B. Walter, Robert L. Atmar, Marc Fischer, Emmanuel Walter, Robert L. Atmar, Elizabeth Barnett, Alan Barrett, Joseph A. Bocchini, Lin Chen, Eric Deussing, Doran Fink, Michael Holbrook, Myron Levin, Anthony Marfin, Cody Meissner, Ro MMWR. Recommendations and Reports.2019; 68(2): 1. CrossRef
First
Prev
